Mechanisms underlying hypoxia-induced neuronal apoptosis

Progress in Neurobiology

Volumn 62, Issue 3, 2000, Pages 215-249

  Banasiak, Kenneth J ^a   Xia, Ying ^b   Haddad, Gabriel G ^b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CASPASE; CYTOKINE; DNA FRAGMENT; EXCITATORY AMINO ACID; LIPOCORTIN 5; NEUROTROPHIC FACTOR; POTASSIUM ION; SODIUM ION;

APOPTOSIS; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL DEATH; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HYPOXIA; MITOCHONDRIAL MEMBRANE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; NEURONS;

EID: 0034739736     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(00)00011-3     Document Type: Review

References (467)

1. Adams J.M., Cory S. The bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
2. An W.G., Kanekal M., Simon M.C., Maltepe E., Blgosklonny M.V., Neckers L.M. Stabilization of wild type p53 by hypoxia-inducible 1. Nature. 392:1998;405-408.
3. Angel P., Imagawa M., Chui R., Stein B., Imbra R.J., Rhamsdorf H.J., Jonal C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 49:1987;729-739.
4. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
5. Ankarcrona M., Dypbukt J.M., Orrenius S., Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 394:1996;321-324.
6. Antonawich F.J., Krajewski S., Reed J.C., Davis J.N. Bcl-x(l) Bax interaction after transient global ischemia. J. Cereb. Blood Flow Metab. 18:1998;882-886.
7. Antonawich F.J., Federoff H.J., Davis J.N. BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia. Exp. Neurol. 156:1999;130-137.
8. Antonsson B., Conti F., Ciavatta A., Montessuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J.J., Mazzei G., Maundrell K., Gambale F., Sadoul R., Martinou J.C. Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:1997;370-372.
9. Apte S.S., Mattei M.G., Olsen B.R. Mapping of the human BAX gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, BAX delta. Genomics. 26:1995;592-594.
10. Ashkenazi A., Dixit V.M. Death receptors: signaling ang modulation. Science. 281:1998;1305-1308.
11. Avantaggiati M.L., Ogryzko V., Gardner K., Giordano A., Levine A.S., Kelly K. Recruitment of p300/ CPB in p53-dependent signal pathways. Cell. 89:1997;1175-1184.
12. + channels. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11703-11708.
13. Baker S.J., Kerppola T.K., Luk D., Vandenberg M.T., Marshak D.R., Curran T., Abate C. Jun is phosphorylated by several protein kinases at the same sites thae are modified in serum-stimulated fibroblasts. Mol. Cell Biol. 12:1992;4694-4705.
14. Bakhshi A., Jemesen J.P., Goldman P., Wright J.J., McBride O.W. Cloning the chromosomal breakpoint of t(14:18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 41:1985;899-906.
15. Bamji S.X., Majdan M., Pozniak C.D., Belliveau D.J., Aloyz R., Kohn J., Causing C.G., Miller F.D. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140:1998;911-923.
16. Ban J., Eckhart L., Weninger W., Mildner M., Tschachler E. Identification of a human cDNA encoding a novel Bcl-x isoform. Biochem. Biophys. Res. Commun. 248:1998;147-152.
17. Banasiak K.J., Haddad G.G. Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797:1998;295-304.
18. Banasiak K.J., Cronin T., Haddad G.G. bcl-2 prolongs neuronal survival during hypoxia-induced apoptosis. Mol. Brain Res. 72:1999;214-225.
19. Barde Y.A. Trophic factors and neuronal survival. Neuron. 2:1989;1525-1534.
20. Bardelli A., Longati P., Albero D., Goruppi S., Schneider C., Ponzetto C., Comoglio P.M. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. Embo J. 15:1996;6205-6212.
21. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor alpha. A mediator of focal ischemic brain injury. Stroke. 28:1997;1233-1244.
22. 2+ and pH. Biochem. Biphys. Res. Commun. 186:1992;783-789.
23. Basanez G., Nechushtan A., Drozhinin O., Chanturiya A., Choe E., Tutt S., Wood K.A., Hsu Y., Zimmerberg J., Youle R.J. Bax, but not Bcl-xL, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc. Natl. Acad. Sci. USA. 96:1999;5492-5497.
24. Basu S., Bayoumy S., Zhang Y., Lozano J., Kolesnick R. BAD enables ceramide to signal apoptosis via Ras and Raf-1. J. Biol. Chem. 273:1998;30419-30426.
25. Baudier J., Delphin C., Grunwald D., Khochbin S., Lawrence J.J. Characterization of the tumor suppressor gene p53 as protein kinase c substrate and an S100b-binding protein. Proc. Natl. Acad. Sci. USA. 89:1992;11627-11631.
26. Behrens M.M., Strasser U., Lobner D., Dugan L.L. Neurotrophin-mediated potentiation of neuronal injury. Micr. Res. Tech. 45:1999;276-284.
27. Belliveau D.J., Krivko I., Kohn J., Lachance C., Pozniak C., Rusakov D., Kaplan D., Miller F.D. NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulate survival and neuritogenesis. J. Cell Biol. 136:1997;375-388.
28. Bernardi P., Broekemeier K.M., Pfeiffer D.R. Recent progress on regulation of the mitochondrial permeability transition pore: a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerget. Biomembr. 26:1994;509-517.
29. Bischoff J.R., Friedman P.N., Marshak D.R., Prives C., Beach D. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc1. Proc. Natl. Acad. Sci. USA. 87:1990;4766-4770.
30. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
31. Boise L.H., Thompson C.B. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:1997;3759-3764.
32. Bokesch P.M., Marchand J.E., Connelly C.S., Wura W.H., Kream R.M. Dextramethorphan inhibits ischemia-induced c-fos expression and delayed neuronal death in hippocampal neurons. Anesthesiology. 81:1994;470-477.
33. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
34. Boniece I.R., Wagner J.A. Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis. J. Neurosci. 13:1993;4220-4228.
35. + efflux in the activation of apoptosis. J. Biol. Chem. 272:1997;32426-32442.
36. Bossenmeyer-Pourie C., Daval J.L. Prevention from hypoxia-induced apoptosis by pre-conditioning: a mechanistic approach in cultured neurons from fetal rat forebrain. Mol. Brain Res. 58:1998;237-239.
37. Bossenmeyer-Pourie C., Chihab R., Schroeder H., Daval J.L. Transient hypoxia may lead to neuronal proliferation in the developing mammalian brain: from apoptosis to cell cycle completion. Neuroscience. 91:1999;221-231.
38. Bossy-Wetzel E., Newmeyer D.D., Green D.R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
39. Botchinka G.I., Meistrtell M.E., Botchinka I.L., Tracey K.J. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol. Med. 3:1997;765-781.
40. Boyd J.M., Gallo G.J., Elangovan B., Houghton A.B., Malstrom S., Avery B.J., Ebb R.G., Subramanian T., Chittenden T., Lutz R.J., et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 11:1995;1921-1928.
41. Brady H.J., Salomons G.S., Bobeldijk R.C., Berns A.J. T cells from bax alpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA-damaged induced cell death in the absence of p53. Embo J. 15:1996;1221-1230.
42. Buckbinder L., Talbott R., Valesco-Miguel S., Takenaka I., Faha B., Seizinger B.R., Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 377:1995;646-649.
43. Calmels S., Hainaut P., Ohshima H. Nitric oxide induces conformational and functional modifications of wild type p53 tumor suppressor protein. Cancer Res. 15:1998;3365-3369.
44. Collaco-Moraes Y., Aspey B.S., deBellaroche J.S., Harrison M.J. Focal ischemia causes an extensive induction of immediate early genes that are sensitive to MK-801. Stroke. 25:1994;1855-1860.
45. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshet E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490.
46. Carmody R.M., McGowan A.J., Cotter T.G. Reactive oxygen species as mediators of photoreceptor apoptosis in vitro. Exp. Cell Res. 248:1999;520-530.
47. Carrier F., Smith M.L., Bae I., Kilpatrick K.E., Lansing T.J., Chen C.Y. Characterization of gadd45, a p53-regulated protein. J. Biol. Chem. 269:1994;32672-32677.
48. Carrier F., Georgel P.T., Pourquier P., Blake M., Kontny H.U., Antinore M.J., Gariboldi M., Myers T.G., Weinstein J.N., Pmmier Y., Fornace A.J. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol. Cell. Biol. 19:1999;1673-1685.
49. Casaccia-Bonnefil P., Gu C., Khursigara G., Chao M.V. p75 neurotrophin receptor as a modulator of survival and death decisions. Micr. Res. Tech. 45:1999;217-224.
50. Chakrabarti S., Hoque A.N., Karmazyn M. A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). J. Mol. Cell Cardiol. 29:1997;3169-3174.
51. Chao D.T., Linette G.P., Boise L.H., White L.S., Thompson C.B., Korsmeyer S.J. Bcl-XL and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182:1995;821-828.
52. Chao D.T., Korsmeyer S.J. Bcl-2 family: regulators of cell death. Annu. Rev. Immunol. 16:1998;395-419.
53. Chao G., Zhen Q., Lorris Betz A., Xiao-Hong L., Guo-Yan Y. Cellular localization of tumor necrosis alpha following focal cerebral ischemia in mice. Brain Res. 801:1998;1-8.
54. Chen I.T., Smith M.L., O'Connor P.M., Fornace A.J. Direct intersction of gadd45 with PCNA and evidence for competitive interaction of gadd45 and p21Waf1/Cip1 with PCNA. Oncogen. 11:1995;1931-1937.
55. Chen J., Graham S.H., Chan P.H., Lan J., Zhou R.L., Simon R.P. bcl-2 is expressed in neurons that survive focal ischemia in the rat. Neuroreport. 6:1995;394-398.
56. Chen J., Zhu R.L., Nakayama M., Kawaguchi K., Jin K., Stetler R.A., Simon R.P., Graham S.H. Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J. Neurochem. 67:1996;64-71.
57. Chen P., Nordstrom W., Gish B., Abrams J.M. Grim, a novel cell death gene in Drosophila. Genes Dev. 10:1996;1773-1782.
58. Chen J., Graham S.H., Nakayama M., Zhu R.L., Jin K., Stetler R.A., Simon R.P. Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia. J. Cereb. Blood Flow Metab. 17:1997;2-10.
59. Chen J., Uchimura K., Stetler R.A., Zhu R.L., Nakayama M., Jin K., Graham S.H., Simon R.P. Transient global ischemia triggers expression of the DNA damage-inducible gene gadd45 in the rat brain. J. Cereb. Blood Flow Metab. 18:1998;846-857.
60. Chen J., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18:1998;4914-4928.
61. Cheng B., Mattson M.P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640:1994;56-67.
62. Cheng B., Mattson M.P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron. 7:1991;1031-1041.
63. Cheng E.H., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., Ueno K., Hardwick J.M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1997;1966-1968.
64. Cheng Y., Deshmukh M., D'Costa A., Demaro J.A., Gidday J.M., Shah A., Sun Y., Jacquin M.F., Johnson E.M., Holtzman D.M. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101:1998;1992-1999.
65. Cheung N.S., Carroll F.Y., Larm J.A., Beart P.M., Giardina S.F. Kainate-induced apoptosis correlates with c-Jun activation in cultured cerebellar granule cells. J. Neurosci. Res. 52:1998;69-82.
66. Chicheportiche Y., Bourdon P.R., Xu H., Hsu Y.M., Scott H., Hession C., Garcia I., Browning J.L. TWEAK, a new secreted ligand in the tumor necrosis factor family tha weakly induces apoptosis. J.Biol. Chem. 272:1997;32401-32410.
67. Chihab R., Bossenmeyer C., Oillet J., Daval J.L. Lack of correlation between the effects of transient exposure to glutamate and those of hypoxia/reoxygenation in immature neurons in vitro. J. Neurochem. 71:1998;1177-1186.
68. Chin L.S., Park C.C., Zitnay K.M., Sinha M., DiPatri A.J. Jr, Perillan P., Simard J.M. J. Neurosci. Res. 48:1997;122-127.
69. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512.
70. Chinnaiyan A.M., Tepper C.G., Seldin M.F., O'Rourke K., Kischkel F.C., Hellbardt S., Krammer P.H., Peter M.E., Dixit V.M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965.
71. Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evan G.I., Guild B.C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736.
72. Chittenden T., Flemington C., Houghton A.B., Ebb R.G., Gallo G.J., Elangovan B., Chinnadurai G., Lutz R.J. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:1995;5589-5596.
73. Chiu R., Boyle W.J., Meek J., Smeal T., Hunter T., Karin M. The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1-responsive genes. Cell. 54:1988;541-552.
74. Chiu R., Angel P., Karin M. Jun B differs in its biological properties from, and is a nefgative regulator of c-jun. Cell. 59:1989;979-986.
75. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:1987;369-379.
76. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 5:1996;667-672.
77. Chow E., Haddad G.G. Differential effects of anoxia and glutamate on cultured neocortical neurons. Exp. Neurol. 150:1998;52-59.
78. Chun L.L., Patterson P.H. Role of nerve growth factor in the development of rat sympathetic neurons in vitro. J. Cell Biol. 75:1977;705-711.
79. Cleary M.L., Sklar J. Nucleotide sequence of a t(14:18) chromosomal breakpoint in follicular lymphoma and a demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA. 82:1985;7439-7443.
80. Clem R.J., Cheng E.H., Karp C.L., Kirsch D.G., Ueno K., Takahashi A., Kastan M.B., Griffin D.E., Earnshaw W.C., Veliuona M.A., Hardwick J.M. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA. 95:1998;554-559.
81. Clemens J.A., Stephenson D.T., Smalstig E.B., Dixon E.P., Little S.P. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke. 28:1997;1073-1080.
82. Clemens J.A., Stephenson D.T., Dixon E.P., Smalstig E.B., Mincy R.E., Rash K.S., Little S.P. Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Mol. Brain Res. 48:1997;187-196.
83. Colom L.V., Diaz M.E., Beers D.R., Neely A., Xie W.J., Appel S.H. Role of potassium channels in amyloid-induced cell death. J. Neurochem. 70:1998;1925-1934.
84. Cosulich S.C., Worrall V., Hedge P.J., Green S., Clarke P.R. Regulation of apoptosis by BH3 domains in a cell-free system. Curr. Biol. 7:1997;913-920.
85. Crook T., Parker G.A., Rozycka M., Crossland S., Allday M.J. A transforming p53 mutant, which binds DNA, transactivates and induces apoptosis reveals a nuclear:cytoplasmic shuttling defect. Oncogene. 16:1998;1429-1441.
86. Cryns V., Yuan J. Proteases to die for. Genes Dev. 12:1998;1551-1570.
87. D'Sa-Eipper C., Subramanian T., Chinnadurai G. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res. 56:1996;3879-3882.
88. D'Sa-Eipper C., Chinnadurai G. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene. 16:1998;3105-3114.
89. Davis P.K., Johnson V.W. Energy metabolism and protein phosphorylation during apoptosis: a phosphorylation study of tau and high-molecular-weight tau in differentiated PC 12 cells. Biochem. J. 340:1999;51-58.
90. Decaudin D., Geley S., Hirsch T., Castedo M., Marchetti P., Macho A., Kofler R., Kroemer G. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57:1997;62-67.
91. DeCoster M.A., Schabelman E., Tombran-Tink J., Bazan N.G. Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons. J. Neurosci. Res. 56:1999;604-610.
92. Delphin C., Cahen P., Lawrence J.J., Baudier J. Characterization of baculovirus recombinant wild type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur. J. Biochem. 223:1994;683-692.
93. Derijard B.B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell. 76:1994;1025-1037.
94. Didier M., Bursztajn S., Adamec E., Passani L., Nixon R.A., Coyle J.T., Wei J.Y., Berman S.A. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J. Neurosci. 16:1996;2238-2250.
95. 2+ fluxes to inhibit apoptosis in thapsigargin- and glucocorticoid-treated mouse lymphoma cells. Cell Calcium. 19:1996;473-483.
96. Dixon E.P., Stephenson D.T., Clemens J.A., Little S.P. Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res. 776:1997;222-229.
97. Dragunow M., Young D., Hughes P., MacGibbon G., Lawlor P., Singleton K., Sirimanne E., Gluckman P. Is c-jun involved in nerve cell death following status epilepticus and hypoxic-ischemic brain injury? Mol. Brain Res. 18:1993;347-352.
98. Dragunow M., Beilharz E., Sirimanne P., Lawlor P., Williams C., Bravo R., Gluckman P. Immediate-early gene protein expression in nueorns undergoing delayed death, but not necrosis, following hypoxic-ischemic injury to the young rat brain. Mol. Brain Res. 25:1994;19-33.
99. Du Y., Bales K.R., Dodel R.C., Hamilton-Byrd E., Horn J.W., Czilli D.L., Simmons L.K., Ni B., Paul S.M. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. U.S.A. 94:1997;11657-11662.
100. Dubinsky J.M., Kristal B.S., Elizondo-Fournier M. An obligate role for oxygen in the early stages of glutamate-induced delayed neuronal death. J. Neurosci. 15:1995;7071-7078.
101. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
102. Elangovan B., Chinnadurai G. Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death. J. Biol. Chem. 272:1997;24494-24498.
103. 2+ ions. J. Cell Biol. 143:1998;217-224.
104. Fabisiak J.P., Kagan V.E., Ritov V.B., Johnson D.E., Lazo J.S. Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis. Am. J. Physiol. 272:1997;675-684.
105. Ferrer I., Pozas E., Lopez E., Ballabriga J. Bcl-2, Bax and Bcl-x expression following hypoxia-ischemia in the infant rat brain. Acta Neuropathol. 94:1997;583-589.
106. Ferrer I., Lopez E., Blanco R., Rivera R., Ballabriga J., Pozas E., Marti E. Bcl-2, Bax, and Bcl-x expression in the CA1 area of the hippocampus following transient forebrain ischemia in the adult gerbil. Exp. Brain Res. 121:1998;167-173.
107. Figiel I., Kaczmarek L. Cellular and molecular correlates of glutamate-evoked neuronal programmed cell death in the in vitro cultures of rat hippocampal dentate gyrus. Neurochem. 31:1997;229-240.
108. Finucane D.M., Bossy-Wetzel E., Waterhouse N.J., Cotter T.G., Green D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 274:1999;2225-2233.
109. i between neonatal and adult rat CA1 neurons in response to anoxia. J. Neurosci. 13:1993;63-72.
110. Friedman J.E., Haddad G.G. Anoxia induces an increase in intracellular sodium in rat central neurons. Brain Res. 663:1994;329-334.
111. Friedman J.E., Haddad G.G. Removal of extracellular sodium prevents anoxia-induced injury in rat CA1 hippocampal neurons. Brain Res. 641:1994;57-64.
112. Furlong I.J., Ascaso R., Rivas A.L., Collins M.K.L. Intracellular acidification induces apoptosis by stimulating ICE-like protease activity. J. Cell Science. 110:1997;653-661.
113. Furlong I.J., Lopez-Mediavilla C., Ascaso R., Lopez-Rivas A., Collins M.K. Induction of apoptosis by valinomycin: mitochondrial permeability transition causes intracellular acidification. Cell Death Differ. 5:1998;214-221.
114. Gary D.S., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cerb. Blood Flow Metab. 18:1998;1283-1287.
115. Gass P., Spranger M., Herdegen T., Kck P., Bravo R., Hacke W., Kiessling M. Induction of fos and jun proteins after focal ischemia in rat: diffrential effect of the N-methyl-D-asparte receptor antagonist MK801. Acta Neuropathol. 84:1992;545-553.
116. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
117. Giaccia A.J., Kastan M.B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:1998;2973-2983.
118. Gibson L., Holmgreen S.P., Huang D.C., Bernard O., Copeland N.G., Jenkins N.A., Sutherland G.R., Baker E., Adams J.M., Cory S. bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene. 13:1996;665-675.
119. Gil-Gomez G., Berns A., Brady H.J. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. Embo J. 17:1998;7209-7218.
120. Gillardon F., Lenz C., Waschke K.F., Krajewski S., Reed J.C., Zimmermann M., Kuschinsky W. Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Mol. Brain Res. 49:1996;254-260.
121. Goga A., Liu X., Hambuch T.M., Senechal K., Major E., Berk A.J., Witte O.N., Sawyers C.L. p53-dependent growth suppression by c-abl nuclear tyrosine kinase. Oncogene. 11:1995;791-799.
122. Goldman S.C., Chen C.Y., Lansing T.J., Gilmer T.M., Kastan M.B. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplamsic localization. Am. J. Pathol. 148:1996;1381-1385.
123. Gonzalez-Garcia M., Garcia I., Ding L., O'Shea S., Boise L.H., Thompson C.B., Nunez G. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA. 92:1995;4304-4308.
124. Goping I.S., Gross A., Lavoie J.N., Nguyen M., Jemmerson R., Roth K., Korsmeyer S.J., Shore G.C. Regulated targeting of BAX to mitochondria. J. Cell Biol. 143:1998;207-215.
125. Gottron F.J., Ying H.S., Choi D.W. Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol. Cell Neurosci. 9:1997;159-169.
126. Graeber T.G., Peterson J.F., Tsai M., Fornace A.J., Giaccia A.J. Hypoxia induces the accumulation of p53 protein, but activation of G1-phase checkpoint by low oxygen conditions is independent of p53 status. Mol. Cell Biol. 14:1994;6264-6277.
127. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striasome matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. 87:1990;6912-6916.
128. Greenberg M.E., Greene L.A., Ziff E.B. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J. Biol. Chem. 260:1985;14101-14110.
129. Greenberg M.E., Ziff E.B., Greene L.A. Stimualtion of the neuronal acetylcholine receptors induces rapid gene transcription. Science. 234:1986;80-83.
130. Griffiths G.J., Dubrez L., Morgan C.P., Jones N.A., Whitehouse J., Corfe B.M., Dive C., Hickman J.A. Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol. 144:1999;903-913.
131. Grillot D.A., Gonzalez-Garcia M., Ekhterae D., Duan L., Inohara N., Ohta S., Seldin M.F., Nunez G. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J. Immunol. 158:1997;4750-4757.
132. Gross A., Jockel J., Wei M.C., Korsmeyer S.J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. Embo J. 17:1998;3878-3885.
133. Gross A., Yin X.M., Wang K., Wei M.C., Jockel J., Milliman C., Erdjument-Bromage H., Tempst P., Korsmeyer S.J. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274:1999;1156-1163.
134. Gu W., Roeder R.G. Activation of p53 sequence specific binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
135. Gubits R.M., Burke R.E., Casey-MacIntosh E., Bandele A., Munell F. Immediate-early genes induction after neonatal hypoxia-ischemia. Mol. Brain Res. 18:1993;228-238.
136. Guegan C., Ceballos-Picot I., Chevalier E., Nicole A., Onteniente B., Sola B. Reduction of ischemic damage in NGF-transgenic mice: correlation with enhancement of antioxidant enzyme activities. Neurobiol. Dis. 6:1999;180-189.
137. Gwag B.J., Lobner D., Koh J.Y., Wie M.B., Choi D.W. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neurosci. 68:1995;615-619.
138. Haddad G.G., Jiang C. Mechanisms of anoxia-induced depolarization in brainstem neurons: in-vitro current and voltage clamp studies in the adult rat. Brain Res. 625:1993;261-268.
139. Hagg T., Varon S. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Nat. Acad. Sci. USA. 90:1993;6315-6319.
140. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S.A., Lowe S.W., Penninger J.M., Mak T.W. Differential requirement for caspase-9 in apoptotiv pathways in vivo. Cell. 94:1998;339-352.
141. Hainaut P., Milner J. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res. 53:1993;1739-1742.
142. Hainaut P., Milner J. Redox modulation of p53 conformation and sequence specific DNA binding in vitro. Cancer Res. 53:1993;4469-4473.
143. Hall P.A., Kearsey J.M., Coates P.J., Norman D.G., Warbrick E., Coz L.S. Characterization of the interaction between PCNA and gadd45. Oncogene. 10:1995;2427-2433.
144. Hall S.R., Campbell L.E., Meek D.W. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation. Nucleic Acids Res. 24:1996;1119-1126.
145. Hansen R., Oren M. p53: from inductive signal to cellular effect. Curr. Opin. Genet. Cell Dev. 7:1997;46-51.
146. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
147. Hara A., Iwai T., Niwa M., Uematsu T., Yoshimi N., Tanaka T., Mori H. Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia. Brain Res. 711:1996;249-253.
148. He H., Lam M., McCormick T.S., Distelhorst C.W. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J. Cell Biol. 138:1997;1219-1228.
149. Heacock C.S., Sutherland R.M. Induction characteristics of oxygen regulated proteins. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1287-1290.
150. Hegde R., Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Alnemri E.S. Blk, a BH3-containing mouse protein that interacts with Bcl-2 and Bcl-xL, is a potent death agonist. J. Biol. Chem. 273:1998;7783-7786.
151. Heiden M.G., Chandel N.S., Schumacker P.T., Thompson C.B. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol. Cell. 3:1999;159-167.
152. Hecker D., Page G., Lohrum M., Weiland S., Scheidtmann K.H. Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. Oncogene. 12:1996;953-961.
153. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by jun, fos, and krox, and CREB/ATF proteins. Brain Res. Rev. 28:1998;370-490.
154. Herr I., Martin-Villalba A., Kurz E., Roncaioli P., Schenkel J., Cifone M.G., Debatin K.M. FK506 prevents stroke-induced generation of ceramide and apoptosis signaling. Brain Res. 826:1999;210-219.
155. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-jun activation domain. Genes Dev. 7:1993;2135-2148.
156. + currents via a Ras-and Raf-1-dependent pathway in cultured oligodendrocytes. J. Neurosci. 18:1998;8712-8719.
157. Hill I.E., MacManus J.P., Rasquinha I., Tuor U.I. DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 676:1995;398-403.
158. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
159. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
160. Hohfeld J., Jentsch S. GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1. Embo J. 16:1997;6209-6216.
161. Holinger E.P., Chittenden T., Lutz R.J. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 274:1999;13298-13304.
162. Hollander M.C., Alamo I., Jackman J., Wang M.G., McBride O.W., Fornace A.J. Analysis of the GADD45 gene and its response to DNA damage. J. Biol. Chem. 268:1993;24385-24393.
163. Hollstein M., Rice K., Greenblatt M.S., Soussi T., Fuchs R., Sorli T., Hovig E., Smith-Sorensen B., Montessano R., Harris C.C. Databsae of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22:1994;3551-3555.
164. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:1997;25-27.
165. Honkaniemi J., States B.A., Weinstein P.R., Espinoza J., Sharp F.R. Expression of zinc finger immediate early genes in rat brain after permanent middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 17:1997;636-646.
166. Hou S.T., Tu Y., Buchan A.M., Huang Z., Preston E., Rasquinha I., Robertson G.S., MacManus J.P. Increases in DNA lesions and the DNA damage indicator gadd45 following transient cerebral ischemia. Biochem. Cell Biol. 75:1997;383-392.
167. Hsu H., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
168. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. TNF- dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity. 4:1996;387-396.
169. Hsu S.Y., Kaipia A., McGee E., Lomeli M., Hsueh A.J. Bok is a pro- apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl.
170. Hsu Y.T., Wolter K.G., Youle R.J. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;3668-3672.
171. Hsu S.Y., Lin P., Hsueh A.J. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members. Mol. Endocrinol. 12:1998;1432-1440.
172. Hu Y., Benedict M.A., Wu D., Inohara N., Nunez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA. 95:1998;4386-4391.
173. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmac. Rev. 47:1995;133-178.
174. Hughes P.E., Alexi T., Walton M., Williams C.E., Dragunow M., Clark R.G., Gluckman P.D. Activity and injury-dependent expression of inducible transcription factors, growth factors, and apoptosis-related genes within the central nervous system. Prog. Neurobiol. 57:1998;421-450.
175. Hupp T.R., Lane D.P. Regulation of the crytic sequence-specific DNA binding function of p53 by protein kinases. Cold Spring Harb. Symp. Quant. Biol. 59:1994;195-206.
176. Ibanez C.F., Ebendal T., Barbany G., Murray-Rust J., Blundell T.L., Persson H. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell. 69:1992;329-341.
177. Ikeda J., Terakawa S., Murota S., Morita I., Hirakawa K. Nuclear disintegration as a leading step of glutamate excitotoxicity in brain neurons. J. Neurosci. Res. 43:1996;613-622.
178. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:1999;70-74.
179. Inohara N., Ding L., Chen S., Nunez G. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). Embo J. 16:1997;1686-1694.
180. Inohara N., Gourley T.S., Carrio R., Muniz M., Merino J., Garcia I., Koseki T., Hu Y., Chen S., Nunez G. Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death. J. Biol. Chem. 273:1998;32479-32486.
181. Inohara N., Ekhterae D., Garcia I., Carrio R., Merino J., Merry A., Chen S., Nunez G. Mtd, a novel Bcl-2 family member activates apoptosis in the absence of heterodimerization with Bcl-2 and Bcl-XL. J. Biol. Chem. 273:1998;8705-8710.
182. Isenmann S., Stoll G., Schroeter M., Krajewski S., Reed J.C., Bahr M. Differential regulation of Bax, Bcl-2, and Bcl-X proteins in focal cortical ischemia in the rat. Brain Pathol. 8:1998;49-62.
183. Ishaque A., Al-Rubeai M. Use of intracellular pH and annexin-V flow cytometric assays to monitor apoptosis and its suppression by bcl-2 over-expression in hybridoma cell culture. J. Immunol. Methods. 221:1998;43-57.
184. Jayamaran L., Murthy K.G., Zhu C., Curran T., Xanthoudakis S., Prives C. Identification of redox/repair protein ref-1 as a potent activator of p53. Genes Dev. 11:1997;558-570.
185. Jin K., Chen J., Kawaguchi K., Zhu R.L., Stetler R.A., Simon R.P., Graham S.H. Focal ischemia induces expression of the DNA damage-inducible gene GADD45 in the rat brain. Neuroreport. 7:1996;1707-1802.
186. Johnson D., Lanahan A., Buck C.R., Sehgal A., Morgan C., Mercer E., Bothwell M., Chao M. Expression and structure of the human NGF receptor. Cell. 47:1986;545-554.
187. Joo C.K., Choi J.S., Ko H.W., Park K.Y., Sohn S., Chun M.H., Oh Y.J., Gwag B.J. Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest. Ophthalmol. Vis. Sci. 40:1999;713-720.
188. Juin P., Pelletier M., Oliver L., Tremblais K., Gregoire M., Meflah K., Vallette F.M. Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J. Biol. Chem. 273:1998;17559-17564.
189. Jurgensmeier J.M., Krajewski S., Armstrong R.C., Wilson G.M., Oltersdorf T., Fritz L.C., Reed J.C., Ottilie S. Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe. Mol. Biol. Cell. 8:1997;325-339.
190. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95:1998;4997-5002.
191. Kamijo T., Weber J.D., Zambetti G., Zindy F., Rossel M.F., Sherr C.J. Functional and physical interactions of the ARF tumor suppressor with p53 and mdm2. Proc. Natl Acad. Sci. USA. 95:1998;8292-8297.
192. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
193. Kasof G.M., Goyal L., White E. Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins. Mol. Cell Biol. 19:1999;4390-4404.
194. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
195. Kastan M.B., Zhan Q., El-Deiry W., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. A mammalian cell cycle checkpoint pathway utilizing p53 and gadd45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
196. Kearsey J.M., Coates P.J., Prescott A.R., Warbrick E., Hall P.A. Gadd45 is a nuclear cell cycle regulated protein which interacts withp21/cip1. Oncogene. 11:1995;1675-1683.
197. Kelekar A., Chang B.S., Harlan J.E., Fesik S.W., Thompson C.B. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell Biol. 17:1997;7040-7046.
198. Kharbanda S., Pandey P., Schofield L., Israels S., Roncinske R., Yoshida K., Bharti A., Yuan Z.M., Saxena S., Weichselbaum R., Nalin C., Kufe D. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;6939-6942.
199. Kiefer M.C., Brauer M.J., Powers V.C., Wu J.J., Umansky S.R., Tomei L.D., Barr P.J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:1995;736-739.
200. Kim C.N., Wang X., Huang Y., Ibrado A.M., Liu L., Fang G., Bhalla K. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57:1997;3115-3120.
201. Kinouchi H., Sharp F.R., Chan P.H., Koistinaho A., Sagar S.M., Yoshimoto T. Induction of c-fos, junB, c-jun, and hsp70 mRNA in cortec, thalamus, basal ganglia, and hippocampus following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 14:1994;808-817.
202. Kitagawa K., Matsumoto M., Tsujimoto Y., Ohtsuki T., Kuwabara K., Matsushita K., Yang G., Tanabe H., Martinou J.C., Hori M., Yanagihara T. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke. 29:1998;2616-2621.
203. Kitanaka C., Namiki T., Noguchi K., Mochizuki T., Kagaya S., Chi S., Hayashi A., Asai A., Tsujimoto Y., Kuchino Y. Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression: differential effects of Bcl-2 and Bcl-xL on Bax-induced caspase activation and apoptosis. Oncogene. 15:1997;1763-1772.
204. Kiyota Y., Takami K., Iwane M., Shino A., Miyamoto M., Tsukuda R., Nagaoka A. Increased in basic fibroblastt growth factor-like immunoreactivity in rat brain after forebrain ischemia. Brain Res. 545:1991;322-328.
205. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
206. Knippschild U., Milne D.M., Campbell L.E., DeMaggio A.J., Christenson E., Hoekstra M.F., Meek D.W. p53 is phosphorylated in vitro and in vivo by the delta and epsilon forms of casein kinase I and enhances the level of casein kinase delta in response to topisomerase-directed drugs. Oncogene. 15:1997;1727-1736.
207. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., McGarry T.J., Kirschner M.W., Koths K., Kwiatkowski D.J., Williams L.T. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 278:1997;294-298.
208. Kovary K., Bravo R. Expression of different jun and fos proteins during the G0-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell Biol. 11:1991;2451-2459.
209. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., Reed J.C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:1993;4701-4714.
210. Krajewski S., Mai J.K., Krajewska M., Sikorska M., Mossakowski M.J., Reed J.C. Upregulation of bax protein levels in neurons following cerebral ischemia. J. Neurosci. 15:1995;6364-6376.
211. Krajewski S., Krajewski M., Ellerby L.M., Welsh K., Xie Z., Deveraux Q.L., Salvesen G.S., Bredesen D.E., Rosenthal R.E., Fiskum G., Reed J.C. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5752-5757.
212. Kruman I., Guo Q., Mattson M.P. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51:1998;293-308.
213. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
214. Kuida K., Haydar T.F., Kuan C.Y., Gu Y., Taya C., Karasuyama H., Su M.S., Rakic P., Flavell R.A. Reduced apoptosis and caspase-mediated activation in mice lacking caspase-9. Cell. 94:1998;325-337.
215. Kuo T.H., Kim H.R., Zhu L., Yu Y., Lin H.M., Tsang W. Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene. 17:1998;1903-1910.
216. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M., Avruch J., Woddgett J.R. The stress-activated protein kinase subfamily of c-jun kinases. Nature. 369:1994;156-160.
217. 2+ fluxes. Proc. Natl. Acad. Sci. USA. 91:1994;6569-6573.
218. Lam M., Bhat M.B., Nunez G., Ma J., Distelhorst C.W. Regulation of Bcl-xl channel activity by calcium. J. Biol. Chem. 273:1998;17307-17310.
219. Larm J.A., Cheung N.S., Beart P.M. Apoptosis induced via AMPA-selective glutamate receptors in cultured murine cortical neurons. J. Neurochem. 69:1997;617-622.
220. Lavine S.D., Hofman F.M., Zlokovic B.V. Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J. Cereb. Blood Flow Metab. 18:1998;52-58.
221. Lawrence M.S., Ho D.Y., Sun G.H., Steinberg G.K., Sapolsky R.M. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci. 16:1996;486-496.
222. Lawrence M.S., McLaughlin J.R., Sun G.H., Ho D.Y., McIntosh L., Kunis D.M., Sapolsky R.M., Steinberg G.K. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J. Cereb. Blood Flow Metab. 17:1997;740-744.
223. Lees-Miller S.P., Chen Y.R., Anderson C.W. Human cells contain a DNA- activated protein kinase that phosphorylates simian virus 40T antigen, mouse p53, and the Ku autoantigen. Mol. Cell Biol. 10:1990;6472-6481.
224. Leist M., Volbracht C., Kuhnle S., Fava E., Ferrando-May E., Nicotera P. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol. Med. 3:1997;750-764.
225. Levi-Montalcini R., Booker B. Destruction of the sympathetic ganglia in mammals by an anti-serum to the never growth factor. Proc. Nat. Acad. Sci. USA. 46:1960;384-391.
226. Levi-Montalcini, R., 1987. The nerve growth factor 35 years later. Science 237, 154-62.
227. Levi-Montalcini R., Angeletti P.U. Immunosympathectomy. Pharmacol. Rev. 18:1966;619-628.
228. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;328-331.
229. Li F., Srinivasan A., Wang Y., Armstrong R.C., Tomaselli K.J., Fritz L.C. Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity independent of cytochrome c release. J. Biol. Chem. 272:1997;30299-30305.
230. Li P., Nijhawan D., Budihardjo D., Srinivasula S.M., Ahmad M., Almeri E.S., Wang X. Cytochrome c and ATP-dependent formation of Apaf1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
231. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
232. Li R., Bernd P. Neurotrophin-3 increases neurite outgrowth and apoptosis in explants of the chicken neural plate. Dev. Neurosci. 21:1999;12-21.
233. Li Y., Chopp M., Jiang N., Zhang Z.G., Zaloga C. Induction of DNA fragmentation after 10 to 120 min of focal cerebral ischemia in rats. Stroke. 26:1995;1252-1257.
234. Lill N.L., Grossman S.R., Ginsberg D., DeCaprio J., Livingston D.M. Binding and modulation of p53 by p300/CPB coactivators. Nature. 387:1997;823-827.
235. Lin A., Frost J., Deng T., Smeal T., Al-Alawi N., Kikkawa U., Hunter T., Brenner D., Karin M. Casein kinase II is a negative regulator of c-jun DNA binding and AP-1 activity. Cell. 70:1992;777-789.
236. Lin T.N., Chen J.J., Wang S.J., Cheng J.T., Chi S.I., Shyu A.B., Sun G.Y., Hsu C.Y. Expression of NGFI-B mRNA in a rat focal ischemia-reperfusion model. Mol. Brain Res. 43:1996;149-156.
237. Lindsay R.M. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J. Neurosci. 8:1988;2394-2405.
238. Linette G.P., Li Y., Roth K., Korsmeyer S.J. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. USA. 93:1996;9545-9552.
239. Linnik M.D., Zobrist R.H., Hatfield M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 24:1993;2002-2008.
240. Linnik M.D., Zahos P., Geschwind M.D., Federoff H.J. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke. 26:1995;1670-1674.
241. Long X., Boluyt M.O., Hipolito M.L., Lundberg M.S., Zheng J.S., O'Neill L., Cirielli C., Lakatta E.G., Crow M.T. p53 and the hypoxia-induced apoptosis of cardiac myocytes. J. Clin. Invest. 99:1997;2635-2643.
242. Ludwig R.L., Bates S., Vousden K.H. Differential activation of target cellular promotersby p53 mutants with impaired apoptotic function. Mol. Cell Biol. 16:1996;4952-4960.
243. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
244. Ma E., Haddad G.G. Anoxia regulates gene expression in the central nervous system of Drosophila melanogaster. Mol. Brain Res. 46:1997;325-328.
245. MacManus J.P., Rasquinha I., Black M.A., Laferriere N.B., Monette R., Walker T., Morley P. Glutamate-treated rat cortical neuronal cultures die in a way different from the classical apoptosis induced by staurosporine. Exp. Cell Res. 233:1997;310-320.
246. Maheswaran S., Englert C., Bennet P., Heinrich G., Haber D.A. The wt1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 9:1995;2143-2156.
247. Maki G.G., Howley P.M. Ubiquitination of p53 and p21 is differentially affected by ionizing radiation and UV radiation. Mol. Cell Biol. 17:1997;355-363.
248. Maltzman W., Czyzyk L. UV radiation stimulates levels of p53 tumor antigen in nontransformed mouse cells. Mol. Cell Biol. 4:1984;1689-1694.
249. Manev H., Kharlamov E., Uz T., Mason R.P., Cagnoli C.M. Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells. Exp. Neurol. 146:1997;171-178.
250. Manon S., Chaudhuri B., Guerin M. Release of cytochrome c and decrease of cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-xL. FEBS Lett. 415:1997;29-32.
251. Mariani S.M., Matiba B., Armandola E.A., Krammer P.H. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell Biol. 137:1997;221-229.
252. 2+. Oncogene. 12:1996;2259-2266.
253. Marsters S.A., Sheridan J.P., Donahue C.J., Pitti R.M., Gray C.L., Goddard A.D., Bauer K.D., Ashkenazi A. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr. Biol. 6:1996;1669-1676.
254. Marsters S.A., Sheridan J.P., Pitti R.M., Brush J., Goddard A., Ashkenazi A. Identification of a ligand for the death-domain-containing receptor Apo3. Curr. Biol. 8:1998;525-528.
255. Martin D.P., Schmidt R.E., DiStefano P.S., Lowry O.H., Carter J.G., Johnson E.M. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by never growth factor deprivation. J. Cell Biol. 106:1988;829-844.
256. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T., Debatin K.M. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19:1999;3809-3817.
257. Martinez-Lorenzo M.J., Alava M.A., Gamen S., Kim K.J., Chuntharapai A., Pineiro A., Naval J., Anel A. Involvment of Apo2 ligand/TRAIL in actication-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28:1998;2714-2725.
258. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
259. Martinou I., Missotten M., Fernandez P.A., Sadoul R., Martinou J.C. Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons. Neuroreport. 9:1998;15-19.
260. Marzo I., Brenner C., Zamzami N., Jurgensmeier J.M., Susin S.A., Vieira H.L., Prevost M.C., Xie Z., Matsuyama S., Reed J.C., Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
261. Mason R.P., Leeds P.R., Jacob R.F., Hough C.J., Zhang K.G., Mason P.E., Chuang D.M. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J. Neurochem. 72:1999;1448-1456.
262. Matsushita K., Matsuyama T., Kitagawa K., Matsumoto M., Yanagihara T., Sugita M. Alterations of Bcl-2 family proteins precede cytoskeletal proteolysis in the penumbra, but not in infarct centres following focal cerebral ischemia in mice. Neuroscience. 83:1998;439-448.
263. Matsuyama S., Xu Q., Velours J., Reed J.C. The Mitochondrial F0F1- ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell. 1:1998;327-336.
264. Matsuyama T., Hata R., Tagay M., Yamamoto Y., Nakajima T., Furuyama J., Wanaka A., Sugita M. Fas antigen mRNA induction in postischemic murine brain. Brain Res. 657:1994;342-346.
265. Matsuyama T., Hata R., Yamamoto Y., Tagaya M., Akita H., Uno H., Wanaka A., Furuyama J., Sugita M. Localization of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridization. Mol. Brain Res. 54:1995;166-172.
266. Mattson M.P., Scheff S.W. Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma. 11:1994;3-33.
267. McCarthy N.J., Whyte M.K., Gilbert C.S., Evan G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215-227.
268. McCormick W., Penman S. regulation of protein synthesis in HeLa cells: translation at elevated temperatures. J. Mol. Biol. 39:1969;315-333.
269. McFarlane M., Ahamad M., Srinivasula S.M., Fernandez-Alnemri T., Cohen G.M., Alnemri E.S. Identification and cloning of two novel receptors for the cytotoxic ligand TRAIL. J.Biol. Chem. 272:1997;25417-25420.
270. Meers P., Mealy T. Calcium-dependent annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative charge. Biochemistry. 32:1993;11711-11721.
271. Meistrell M.E., Botchinka G.I., Wang H., Di Santo E., Cockroft K.M., Bloom O., Vishnubhakat J.M., Ghezzi P., Tracey K.J. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock. 8:1997;341-348.
272. Merad-Boudia M., Nicole A., Santiard-Baron D., Saille C., Ceballos-Picot I. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem. Pharmacol. 56:1998;645-655.
273. Metz R., Bannister A.J., Sutherland J.A., Hagemeier C., O'Rourke E.C., Cook A., Bravo R., Kouazrides T. C-fos-induced activation of a TATA box-containing promoter involvesbdirect contact with TATA-box-binding protein. Mol. Cell Biol. 14:1994;6021-6029.
274. Meyer K.M., Fiskum G., Liu Y., Simmnes S.J., Bredesesn D.E., Murphy A.N. Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid, oxidation, mitochondrial injury, and loss of viability. J. Neurochem. 65:1995;2432-2440.
275. Midgley C.A., Lane D.P. p53 protein stability in tumor cells is not determined by mutation but is dependent on mdm2 binding. Oncogene. 15:1997;1179-1189.
276. Milne D.M., Palmer R.H., Campbell D.G., Meek D.W. Phoisphorylation of the p53 tumor-suppressor protein at three N-terminal sites by a novel casein kinase-I-like enzyme. Oncogene. 7:1992;1361-1369.
277. Minden A., Lin A., Smeal T., Derijard B., Cobb M., Davis R., Karin M. C-jun-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell Biol. 14:1994;6683-6688.
278. Mitchell J.J., Paiva M., Walker D.W., Heaton M.B. BDNF and NGF afford in vitro neuroprotection against ethanol combined with acute ischemia and chronic hypoglycemia. Dev. Neurosci. 21:1999;68-75.
279. Moll U.M., Riou G., Levine A.J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA. 89:1992;7262-7266.
280. Moll U.M., LaQuaglia M., Bernard J., Riou G. Wild type p53 undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA. 92:1995;4407-4411.
281. Momand J., Zambetti G.P., Olson D.C., Geoge D.L., Levine A.J. The mdm-2 oncogene product forms a complex with p53 protein and inhibits p53-mediated transactivation. Cell. 69:1992;12337-12345.
282. Monaghan P., Robertson D., Amos T.A., Dyer M.J., Mason D.Y., Greaves M.F. Ultrastructural localization of bcl-2 protein. J. Histochem. Cytochem. 40:1992;1819-1825.
283. Montal M. Mitochondria, glutamate neurotoxicity and the death cascade. Biochim. Biophys. Acta. 1366:1998;113-126.
284. Morana S.J., Wolf C.M., Li J., Reynolds J.E., Brown M.K., Eastman A. The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis. J. Biol. Chem. 271:1996;18263-18271.
285. Morgan J.I., Curran T. Role of ion flux in the control of c-fos expression. Nature. 322:1986;552-555.
286. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:1991;421-451.
287. Moss S.F., Agarwal B., Arber N., Guan R.J., Krajewska M., Krajewski S., Reed J.C., Holt P.R. Increased intestinal Bak expression results in apoptosis. Biochem. Biphys. Res. Commun. 223:1996;199-203.
288. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., Nettesheim D., Chang B.S., Thompson C.B., Wong S.L., Ng S.L., Fesik S.W. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
289. Murphy A.N., Bredesen D.E., Cortopassi G., Wang E., Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. USA. 93:1996;9893-9898.
290. Muzio M., Salvesen G.S., Dixit V.M. FLICE-induced apoptosis in a cell-free system, Cleavage of caspase zymogens. J. Biol. Chem. 272:1997;2952-2956.
291. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:1998;2926-2930.
292. Myashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
293. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
294. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K.J., Yuan J., Moskowitz M.A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
295. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95:1998;14681-14686.
296. Nath R., Probert A. Jr, McGinnis K.M., Wang K.K. Evidence for activation of caspase-3-like protease in excitotoxin- and hypoxia/hypoglycemia-injured neurons. J. Neurochem. 71:1998;186-195.
297. Nawashiro H., Martin D., Hallenbeck J.M. Neuroprotective effects of TNF binding protein in Focal cerebral ischemia. Brain Res. 778:1997;265-271.
298. Neame S.J., Rubin L.L., Philpott K.L. Blocking cytochrome c activity within intact neurons inhibits apoptosis. J. Cell Biol. 142:1998;1583-1593.
299. Nicholson D.W., Thorn berry N.A. Caspases: killer proteases. Trends Biochem Sci. 22:1997;299-306.
300. Nicotera P., Zhivotovsky B., Orrenius S. Nuclear calcium transport and the role of calcium in apoptosis. Cell Calcium. 16:1994;279-288.
301. 2+: physiological regulation and role in apoptosis. Mol. Cell. Biochem. 135:1994;89-98.
302. Nicotera P., Leist M., Manzo L. Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci. 20:1999;46-51.
303. Nikolakaki E., Coffer P.J., Hemelsoet R., Woodgett J.R., Defize L.H.K. Glycogen synthase kinase 3 phosphorylates jun family members in vitro and nebatively regulates their transactivating potential in intact cells. Oncogene. 8:1993;833-840.
304. Nitta A., Ohmiya M., Sometani A., Itoh M., Nomoto H., Furukawa Y., Furukawa S. Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone. J. Neurosci. Res. 57:1999;227-235.
305. Niwa M., Hara A., Iwai T., Sassa T., Mori H., Uematsu T. Expression of Bax and Bcl-2 protein in the gerbil hippocampus following transient forebrain ischemia and its modification by phencyclidine. Neurol Res. 19:1997;629-633.
306. Ng F.W., Nguyen M., Kwan T., Branton P.E., Nicholson D.W., Cromlish J.A., Shore G. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell Biol. 139:1997;327-338.
307. Ng F.W., Shore G.C. Bcl-XL cooperatively associates with the Bap31 complex in the endoplasmic reticulum, dependent on procaspase-8 and Ced-4 adaptor. J. Biol. Chem. 273:1998;3140-3143.
308. Nonaka S., Hough C.J., Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2642-2647.
309. Nomura Y. A transient brain ischemia- and bacterial endotoxin-induced glial iNOS expression and NO-induced neuronal apoptosis. Toxixol. Lett. 102:1998;65-69.
310. O'Connor L., Strasser A., O'Reilly L.A., Hausmann G., Adams J.M., Cory S., Huang D.C. Bim: a novel member of the Bcl-2 family that promotes apoptosis. Embo J. 17:1998;384-395.
311. O'Reilly L.A., Huang D.C., Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. Embo J. 15:1996;6979-6990.
312. Ohgoh M., Kimura M., Ogura H., Katayama K., Nishizawa Y. Apoptotic cell death of cultured cerebral cortical neurons induced by withdrawal of astroglial trophic support. Exp. Neurol. 149:1998;51-63.
313. Oliner J.D., Pitenepol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Oncoprotein mdm2 conceals the activation domain of tumor suppressor p53. Nature. 362:1993;857-860.
314. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
315. + ratio blocks apoptosis in vascular smooth muscle at a site upstream of caspase-3. J. Biol. Chem. 274:1999;16545-16552.
316. Orth K.I., Chinnayan A.M., Garg M., Froehilch C.J., Dixit V.M. The ced-3/ICE-like protease mch2 is activated during apoptosis and cleaves the death substrate lamin. J. Biol. Chem. 271:1996;16443-16446.
317. Ottilie S., Diaz J.L., Horne W., Chang J., Wang Y., Wilson G., Chang S., Weeks S., Fritz L.C., Oltersdorf T. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J. Biol. Chem. 272:1997;30866-30872.
318. Otter I., Conus S., Ravn U., Rager M., Olivier R., Monney L., Fabbro D., Borner C. The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli. J. Biol. Chem. 273:1998;6110-6120.
319. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., Dixit V.M. The receptor for the cytotoxic ligand TRAIL. Science. 276:1997;111-113.
320. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for trail. Science. 277:1997;815-817.
321. Pan G., O'Rourke K., Dixit V.M. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273:1998;5841-5845.
322. + exchanger. Am. J. Physiol. 276:1999;H1581-H1590.
323. Perlman H., Sata M., Le Roux A., Sedlak T.W., Branellec D., Walsh K. Bax-mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity. Embo J. 17:1998;3576-3586.
324. Perlman H., Zhang X., Chen M.W., Walsh K., Buttyan R. An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ. 6:1999;48-54.
325. Perez-Sala D., Collado-Escobar D., Mollinedo F. Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cell through the inactivation of pH-dependent endonuclease. J. Biol. Chem. 270:1995;6235-6242.
326. Petterson E.O., Juul N.O., Ronning O.W. Regulation of protein metabolism of human cells during and after acute hypoxia. Cancer Res. 46:1986;4346-4351.
327. Piantadosi C.A., Zhang J., Levin E.D., Folz R.J., Schmechel D.E. Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp. Neurol. 147:1997;103-114.
328. Pomerantz J., Schreiber-Agus N., Liegeois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H.W., Cordon-Cardo C., DePinho R.A. The ink4a tumor suppressor gene product, p19arf interacts with mdm2 and neutralizes mdm2's inhibition of p53. Cell. 92:1998;713-723.
329. Portera-Cailliau C., Price D.L., Martin L.J. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J. Comp. Neurol. 378:1997;70-87.
330. Priault M., Camougrand N., Chaudhuri B., Manon S. Role of the C- terminal domain of Bax and Bcl-XL in their localization and function in yeast cells. FEBS Lett. 443:1999;225-228.
331. Price B.D., Calderwood S.K. Gadd45 and gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res. 52:1992;3814-3817.
332. Price B.D., Calderwood S.K. Increased specific DNA-binding activity after DNA damage is attenuated by phorbol esters. Oncogene. 8:1993;3055-3062.
333. Price B.D., Hughes-Davies L., Park S.J. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. Oncogene. 11:1995;73-80.
334. Pulera M.R., Adams L.M., Liu H., Santos D.G., Nishimura R.N., Yang F., Cole G.M., Wasterlain C.G. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke. 29:1998;2622-2630.
335. Puthalakath H., Huang D.C., O'Reilly L.A., King S.M., Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell. 3:1999;287-296.
336. Radeke M.J., Misko T.P., Hsu C., Herzenberg L.A., Shooter E.M. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature. 325:1987;593-597.
337. Reynolds J.E., Li J., Craig R.W., Eastman A. BCL-2 and MCL-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine. Exp. Cell Res. 225:1996;430-436.
338. Rheaume E., Cohen L.Y., Uhlmann F., Lazure C., Alam A., Hurwitz J., Sekaly R.P., Denis F. The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase-3-like protease during Fas-mediated apoptosis. Embo J. 16:1997;6346-6354.
339. Rong P., Bennie A.M., Epa W.R., Barrett G.L. Nerve growth factor determines survival and death of PC12 cells by regulation of the bcl-x, bax, and caspase-3 genes. J. Neurochem. 72:1999;2294-2300.
340. Rosenbaum D.M., Rosenbaum P.S., Gupta H., Singh M., Aggarwal A., Hall D.H., Roth S., Kessler J.A. The role of the p53 protein in the selective vulnerability of the inner retina to transient ischemia. Invest. Ophthalmol. Vis. Sci. 39:1998;2132-2139.
341. Roth J., Dobbelstein M., Freedman D.A., Shenk T., Levine A.J. Nucleo- cytoplasmic shuttling of the mdm2 on coproteinregulates the levels of p53 protein via pathways used by the human immunodeficiency virus rev protein. Embo J. 17:1998;554-564.
342. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., Goeddel D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
343. Rotonda J., Nicholson D.W., Fazil K.M., Gallant M., Gareau Y., Labelle M., Peterson E.P., Rasper D.M., Ruel R., Vaillancourt J.P., Thornberry N.A., Becker J.W. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nature Struct. Biol. 3:1995;619-625.
344. Rouayrenc J.F., Boise L.H., Thompson C.B., Privat A., Patey G. Presence of the long and the short forms of Bcl-X in several human and murine tissues. C. R. Acad. Sci. III. 318:1995;537-540.
345. Roux P.P., Colicos M.A., Barker P.A., Kennedy T.E. p75 neurotrophin receptor expression is induced in apoptotic neurons after seizure. J Neurosci. 19:1999;6887-6896.
346. Rudel T., Bokoch G.M. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science. 276:1997;1571-1574.
347. Ruit K.G., Osborne P.A., Schmidt R.E., Johnson E.M., Snider W.D. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J. Neurosci. 10:1990;2412-2419.
348. Ryan K.M., Vousden K.H. Characterization of structural p53 mutants which show selective defects in apoptosis but cell cycle arrest. Mol. Cell Biol. 18:1998;3692-3698.
349. Ryseck P., Bravo R. c-Jun, jun B, and jun D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of fos proteins. Oncogene. 6:1991;533-542.
350. Saikumar P., Dong Z., Patel Y., Hall K., Hopfer U., Weinberg J.M., Venkatachalam M.A. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene. 17:1998;3401-3415.
351. Santella L., Carafoli E. Calcium signaling in the cell nucleus. FASEB J. 13:1997;1091-1109.
352. Sairanen T.R., Lindsberg P.J., Brenner M., Siren A.L. Global forebrain ischemia results in differential cellular expression of interleukin 1 beta (IL-beta) and its receptor at mRNA and protein level. J. Cereb. Blood Flow Metab. 17:1997;1107-1120.
353. Sakurai M., Hayashi T., Abe K., Sadahiro M., Tabayashi K. Delayed selective motor neuron death and fas antigen induction after spinal cord ischemia in rabbits. Brain Res. 797:1998;23-28.
354. Sassone-Corsi P., Sisson J.C., Verna I.M. Transcriptional autoregulation of the proto-oncogene c-fos. Nature. 334:1988;314-319.
355. Sato T., Hanada M., Bodrug S., Irie S., Iwama N., Boise L.H., Thompson C.B., Golemis E., Fong L., Wang H.G. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci USA. 91:1994;9238-9242.
356. Satoh T., Sakai N., Enokido Y., Uchiyama Y., Hatanaka H. Free radical-independent protection by nerve growth factor and Bcl-2 of PC12 cells from hydrogen peroxide-triggered apoptosis. J. Biochem. (Tokyo). 120:1996;540-546.
357. Sattler M., Liang H., Nettesheim D., Meadows R.P., Harlan J.E., Eberstadt M., Yoon H.S., Shuker S.B., Chang B.S., Minn A.J., Thompson C.B., Fesik S.W. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science. 275:1997;983-986.
358. Schendel S.L., Xie Z., Montal M.O., Matsuyama S., Montal M., Reed J.C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94:1997;5113-5118.
359. Schlesinger P.H., Gross A., Yin X.M., Yamamoto K., Saito M., Waksman G., Korsmeyer S.J. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. U.S.A. 94:1997;11357-11362.
360. Schutte J., Viallet J., Nau M., Segal S., Fedorko J., Minna J. Jun-B inhibits and c-fos stimulates the transforming and transactivating activities of c-jun. Cell. 59:1989;987-997.
361. Scolnick D.M., Chehab N.H., Stavridi E.S., Lien M.C., Caruso L., Moran E., Berger S.L., Halazonetis T.D. CREB binding protein and p300/CPB-associated factor are transcriptional activators of the p53 tumor suppressor protein. Cancer Res. 57:1997;3693-3696.
362. Scotto C., Deloulme J.C., Rousseau D., Chambaz E., Baudier J. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell. Biol. 18:1998;4272-4281.
363. Scheid M.P., Duronio V. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc. Natl. Acad. Sci. USA. 95:1998;7439-7444.
364. Schneider P., Bodmer J.L., Thome M., Hofmann K., Holler N., Tschopp J. Characterization of two receptors for TRAIL. FEBS Lett. 416:1997;329-334.
365. Schulz J.B., Bremen D., Reed J.C., Lommatzsch J., Takayama S., Wullner U., Loschmann P.A., Klockgether T., Weller M. Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1 expression: prevention of caspase activation and reduced production of reactive oxygen species. J. Neurochem. 69:1997;2075-2086.
366. Schulz J.B., Weller M., Matthews R.T., Heneka M.T., Groscurth P., Martinou J.C., Lommatzsch J., von Coelln R., Wullner U., Loschmann P.A., Beal M.F., Dichgans J., Klockgether T. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ. 5:1998;847-857.
367. Screaton G.R., Mongkolsapaya J., Xu X.N., Cowper A.E., McMichael A.J., Bell J.I. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr. Biol. 7:1997;693-696.
368. Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., Korsmeyer S.J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA. 92:1995;7834-7838.
369. Sendtner M., Arakawa Y., Stockli K.A., Kreutzberg G.W., Thoenen H. Effect of ciliary neurotrophic factor (CNTF) on motoneuron survival. J. Cell Sci. 15:(Suppl):1991;103-109.
370. Sheng M., Dougan S.T., Mc Fadden G., Greenberg M.E. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol. Cell Biol. 8:1988;2787-2796.
371. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
372. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Goddard A.D., Godowski P., Ashkenazi A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science. 277:1997;818-821.
373. Shi B., Triebe D., Kajiji S., Iwata K.K., Bruskin A., Mahajna J. Identification and characterization of baxepsilon, a novel bax variant missing the BH2 and the transmembrane domains. Biochem. Biophys. Res. Commun. 254:1999;779-785.
374. Shieh S.Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by mdm2. Cell. 91:1997;325-334.
375. Shimazaki K., Ishida A., Kawai N. Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci. Res. 20:1994;95-99.
376. Shimizu S., Eguchi Y., Kamiike W., Funahashi Y., Mignon A., Lacronique V., Matsuda H., Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1455-1459.
377. Smith M.L. Jr, Chen I.T., Zhan Q., Bae I., Chen C.Y., Gilmer T.M., Kastan M.B., O'Connor P.M., Fornace A.J. Interaction of the p53-regulated protein gadd45 with proliferating cell nuclear antigen. Science. 266:1993;1376-1380.
378. Snider W.D. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell. 77:1994;627-638.
379. Simonen M., Keller H., Heim J. The BH3 domain of Bax is sufficient for interaction of Bax with itself and with other family members and it is required for induction of apoptosis. Eur. J. Biochem. 249:1997;85-91.
380. Sobko A., Peretz A., Attali B. Constitutive activation of delayed-rectifier potassium channels by a Src family tyrosine kinase in Schwann cells. EMBO J. 17:1998;4723-4734.
381. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19:1999;5731-5740.
382. Song Q., Kuang Y., Dixit V.M., Vincenz C. Boo, a novel negative regulator of cell death, interacts with Apaf-1. Embo J. 18:1999;167-178.
383. Sonnenberg J.L., Macgregor-Leon P.F., Hempstead J., Morgan J.I., Curran T. Glutamate receptor antagonists increase the expression of fos, fra, and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24:1989;72-80.
384. St. Clair E.G., Anderson S.J., Oltvai Z.N. Bcl-2 counters apoptosis by Bax heterodimerization-dependent and -independent mechanisms in the T-cell lineage. J. Biol Chem. 272:1997;29347-29355.
385. Stoler D.L., Anderson G.R., Russo C.A., Spina A.M., Beerman T.A. Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells. Cancer Res. 52:1992;4372-4378.
386. Stoll G., Jander S., Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56:1998;149-171.
387. Stuart J.K., Myszka D.G., Joss L., Mitchell R.S., McDonald S.M., Xie Z., Takayama S., Reed J.C., Ely K.R. Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperones. J. Biol. Chem. 273:1998;22506-22514.
388. Szaflarski J., Burtrum D., Silverstein F.S. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke. 26:1995;1093-1100.
389. Tabuchi A., Oh E., Taoka A., Sakurai H., Tsuchiya T., Tsuda M. Rapid attenuation of AP-1 transcriptional factors associated with nitric oxide (NO)- mediated neuronal cell death. J. Biol. Chem. 271:1996;31061-31067.
390. Takahashi A., Alnemri E.S., Lazebnik Y.A., Fernandez-Alnemri T., Litwack G., Moir R.D., Goldman R.D., Poirier G.G., Kaufman S.H., Earnshaw W.C. Cleavage of lamin by mch2α but not CPP32: multiple interleukin-1β enzyme-related proteases with distinct substrate activities are active in apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;8395-8400.
391. Takahashi A., Hirata H., Yonehara S., Imai Y., Lee K.K., Moyer R.W., Turner P.C., Mesner P.W., Okazaki T., Savai H., Kishi S., Yamamoto K., Okuma M., Sasada M. Affinity labeling displays the stepwise activation of ICE-related proteases by fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene. 14:1997;2741-2752.
392. + antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system. J. Mol. Cell Cardiol. 27:1995;729-742.
393. 2+ inophore-induced apoptosis on cultured embryonic rat cortical neurons. Brain Res. 651:1994;65-70.
394. Tamatani M., Ogawa S., Tohyama M. Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: a possible neuroprotective mechanism of peptide growth factors. Mol. Brain Res. 58:1998;27-39.
395. Tamatani M., Che Y.H., Matsuzaki H., Ogawa S., Okado H., Miyake S., Mizuno T., Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274:1999;8531-8538.
396. Tan S., Sagara Y., Liu Y., Maher P., Schubert D. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141:1998;1423-1432.
397. Tan Y.J., Beerheide W., Ting A.E. Biophysical characterization of the oligomeric state of Bax and its complex formation with Bcl-XL. Biochem. Biophys. Res. Commun. 255:1999;334-339.
398. Tartaglia L.A., Goeddel D.V. Two TNF receptors. Immunol. Today. 13:1992;151-153.
399. Tao W., Kurschner C., Morgan J.I. Modulation of cell death in yeast by the Bcl-2 family of proteins. J. Biol. Chem. 272:1997;15542-15547.
400. Tenneti L., D'Emilia D.M., Troy C.M., Lipton S.A. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 71:1998;946-959.
401. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunines J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 356:1992;768-774.
402. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., Nicholson D.W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:1997;17907-17911.
403. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
404. Thress K., Henzel W., Shillinglaw W., Kornbluth S. Scythe: a novel reaper-binding apoptotic regulator. EMBO J. 17:1998;6135-6143.
405. Thut C.J., Goodrich J.A., Tijan R. Represion of p53mediated transcription by mdm2: a dual mechanism. Genes Dev. 11:1997;1974-1986.
406. Tomasevic G., Kamme F., Stubberod P., Wieloch M., Wieloch T. The tumor suppressor p53 and its response gene p21Waf1/Cip1 are not markers of neuronal death following transient global cerebral ischemia. Neuroscience. 90:1999;781-792.
407. Trump B.F., Berezesky I.K., Cowley R.A. The cellular and subcellular characteristics of acute and chronic injury with emphasis on the role of calcium. Cowley R.A., Trump B.F. Pathophysiology of shock, anoxia, and ischemia. 1982;6-46 Williams and Wilkins, Baltimore, MD.
408. Tsujimoto Y., Croce C.M. analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA. 83:1986;5214-5218.
409. Uberti D., Belloni M., Grilli M., Spano P., Memo M. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur. J. Neurosci. 10:1998;246-254.
410. van Lookeren-Campagne M., Gill R. Increased expression of cyclin G1 and p21Waf1/Cip1 in neurons following transient forebrain ischemia: comparison with early DNA damage. J. Neurosci. Res. 53:1998;279-296.
411. van Lookeren-Campagne M., Gill R. Cell cycle-related gene expression in adult rat brain: selective induction of cyclin G1 and p21Waf1/Cip1 in neurons following focal cerebral ischemia. Neuroscience. 84:1998;1097-1112.
412. Vander Heiden M.G., Chandel N.S., Williamson E.K., Schumacker P.T., Thompson C.B. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
413. Verhaegh G.W., Richard M.J., Hainaut P. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol. Cell Biol. 17:1997;5699-5706.
414. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 184:1995;39-51.
415. Villa P., Kaufmann S.H., Earnshaw W.C. Caspases and caspase inhibitors. Trends Biochem. Sci. 22:1997;388-393.
416. Vucic D., Kaiser W.J., Miller L.K. Inhibitor of apoptosis proteins physically interact with and block apoptosis induced by Drosophila proteins HID and GRIM. Mol. Cell Biol. 18:1998;3300-3309.
417. Walczak H., Degli-Esposti A., Johnson R.S., Smolak P.J., Waugh J.Y., Boiani N., Timour M.S., Gerhart M.J., Schooley K.A., Smith C.A., Goodwin R.G., Rauch C.T. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. Embo J. 16:1997;5386-5397.
418. Walker N.I., Harmon B.V., Gobe G.C., Kerr J.F.R. Patterns of cell death. Methods Achiev. Exp. Pathol. 13:1988;18-54.
419. Walker N.P., Talanian R.V., Brady K.D., Dang L.C., Bump N.J., Ferenz C.R., Franklin S., Ghayur T., Hackett M.C., Hamill L.D., et al. Cell. 78:1994;343-352.
420. Walker P.R., Weaver V.M., Lach B., LeBlanc J., Sikorska M. Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis. Exp. Cell Res. 213:1994;100-106.
421. Walton M., Connor B., Lawlor P., Young D., Sirimanne E., Gluckman P., Cole G., Dragunow M. Neuronal death and survival in two models of hypoxic- ischemic brain damage. Brain Res. Rev. 29:1999;137-168.
422. Wang H.G., Rapp U.R., Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
423. Wang H.G., Takayama S., Rapp U.R., Reed J.C. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA. 93:1996;7063-7068.
424. Wang K., Yin X.M., Chao D.T., Milliman C.L., Korsmeyer S.J. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:1996;2859-2869.
425. Wang H.G., Reed J.C. Bc1-2, Raf-1 and mitochondrial regulation of apoptosis. Biofactors. 8:1998;13-16.
426. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 284:1999;339-343.
427. + channel mediates apoptosis of myeloblastic leukemia cells. J. Biol. Chem. 274:1999;3678-3685.
428. Wang X.W., Yeh H., Schaeffer L., Roy R., Moncollin V., Egly J.M., Wang J.M., Wang Z., Friedberg E.C., Evans M.K., Taffe B.G., et al. p53 modulation of TFIIH associated nucleotide excision repair activity. Nature Genet. 10:1995;189-195.
429. Wang, X.W., Zhan, Q., Coursen, J.D., Khan, M.A., Kontny, H.U., Yu, L., Hollander, M.C., O'Connor, P.M., Fornace, A.J., Harris, C.C., 1999. Gadd45 induction of a G2/M xcell cycle checkpoint. Proc. Natl. Acad. Sci. USA 96, 3706-3711.
430. Wei H., Wei W., Bredesen D.E., Perry D.C. Bcl-2 protects against apoptosis in neuronal cell line caused by thapsigargin-induced depletion of intracellular calcium stores. J. Neurochem. 70:1998;2305-2314.
431. Weinmann P., Gaehtgens P., Walzog B. Bcl-Xl- and Bax-alpha-mediated regulation of apoptosis of human neutrophils via caspase-3. Blood. 93:1999;3106-3115.
432. Wen L.P., Fahrni J.A., Troie S., Guan J.L., Orth K., Rosen G.D. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272:1997;26056-26061.
433. Whitfield P.C., Williams R., Pickard J.D. Delayed induction of junB precedes CA1 neuronal death after global ischemia in the gerbil. Brain Res. 18:1999;450-458.
434. Wiedau-Pazos M., Trudell J.R., Altenbach C., Kane D.J., Hubbell W.L., Bredesen D.E. Expression of bcl-2 inhibits cellular radical generation. Free Radic. Res. 24:1996;205-212.
435. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673-682.
436. Wilson K.P., Black J.A., Thomson J.A., Kim E.E., Griffith J.P., Navia M.A., Murcko M.A., Chambers S.P., Aldape R.A., Raybuck S.A., et al. Nature. 370:1994;270-275.
437. Wing J.P., Zhou L., Schwartz L.M., Nambu J.R. Distinct cell killing properties of the Drosophila reaper, head involution defective, and grim genes. Cell Death Differ. 5:1998;930-939.
438. Wood A.M., Bristow D.R. N-methyl-d-aspartate receptor desensitisation is neuroprotective by inhibiting glutamate-induced apoptotic-like death. J. Neurochem. 70:1998;677-687.
439. Wu R.C., Schonthal A.H. Activation of p53-p21waf1 pathway in response to disruption of cell-matrix interactions. J. Biol. Chem. 272:1997;29091-29098.
440. Wyllie A.H. Gluocorticoid-induced thymic apoptosis is associated with endogenous nuclease activation. Nature. 284:1980;555-556.
441. Wyllie A.H. Cell death: a new classification separating apoptosis from necrosis. Bowen I.D., Lockshin R.A. Cell Death in Biology and Pathology. 1981;9-34 Chapman and Hall, London.
442. Xiang H., Kinoshita Y., Knudson C.M., Korsmeyer S.J., Schwartzkroin P.A., Morrison R.S. J. Neurosci. 18:1998;1363-1373.
443. Xu Q., Reed J.C. Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell. 1:1998;337-346.
444. Xue D., Horvitz H.R. Caenoehabditis elegans CED-9 protein is a bifunctional cell death inhibitor. Nature. 390:1997;305-308.
445. Yang D.D., Juan C.-Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., Flavell R.A. Nature. 389:1997;865-870.
446. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
447. Yang G.Y., Gong C., Qin Z., Ye W., Mao Y., Bertz A.L. Inhibition of TNF alpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport. 9:1998;2131-2134.
448. Yeh W.C., Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., Shahinian A., Ng M., Wakeham A., Khoo W., Mitchell K., El-Deiry W.S., Lowe S.W., Goeddel D.V., Mak T.W. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 279:1998;1954-1958.
449. Yin X.M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.
450. Yu S.P., Yeh C.H., Sensi S.L., Gwag B.J., Canzoniero L.M.T., Farhangrazi Z.S., Ying H.S., Tian M., Dugan L.L., Choi D.W. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science. 278:1997;114-117.
451. Yu S.P., Farhangrazi Z.S., Ying H.S., Yeh C.H., Choi D.W. Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death. Neurobiol. Dis. 5:1998;81-88.
452. + efflux and neuronal apoptosis. Science. 284:1999;336-339.
453. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta converting enzyme. Cell. 75:1993;641-652.
454. Zamzami N., Brenner C., Marzo I., Susin S.A., Kroemer G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene. 16:1998;2265-2282.
455. Zhang H., Heim J., Meyhack B. Redistribution of Bax from cytosol to membranes is induced by apoptotic stimuli and is an early step in the apoptotic pathway. Biochem. Biophys. Res. Commun. 251:1998;454-459.
456. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 87:1996;619-628.
457. Zha H., Reed J.C. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J. Biol. Chem. 272:1997;31482-31488.
458. Zha J., Harada H., Osipov K., Jockel J., Waksman G., Korsmeyer S.J. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro- apoptotic activity. J. Biol. Chem. 272:1997;24101-24104.
459. Zhai Q.H., Futrell N., Chen F.J. Gene expression of IL-10 in relation to TNF- alpha, IL-1 beta and IL-2 in the rat brain following middle cerebral artery occlusion. J. Neurol. Sci. 152:1997;119-124.
460. Zhan Q., Antinore N.J., Wang X.W., Carrier F., Smith M.L., Harris C.C., Fornace A.J. Anssociation with cdc2 and inhibition of cdc2/cyclinB1 kinase activity by the p53-regulated protein gadd45. Oncogene. 18:1999;2892-2900.
461. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes mdm2 degradation and stabilizes p53: ARF-ink4a locus deletion impairs both the RB and p53 tumor suppression pathways. Cell. 92:1998;725-734.
462. Zhong L.T., Sarafian T., Kane D.J., Charles A.C., Mah S.P., Edwards R.H., Bredesen D.E. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA. 90:1993;4533-4537.
463. Zhou M., Demo S.D., McClure T.N., Crea R., Bitler C.M. A novel splice variant of the cell death-promoting protein BAX. J.Biol. Chem. 273:1998;11930-11936.
464. Zindy F., Eische C.M., Randle D., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:1998;2424-2433.
465. Zong W.X., Edelstein L.C., Chen C., Bash J., Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13:1999;382-387.
466. Zorati M., Szabo I. Electrophysiology of the inner mitochondrial membrane. J. Bioenerget. Biomembr. 26:1994;543-553.
467. Zundel W., Giaccia A. Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. Genes Dev. 12:1998;1941-1946.